看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 503.0x - 556.0x | 529.5x |
| Selected Fwd EBIT Multiple | 7.4x - 8.2x | 7.8x |
| Fair Value | $6.50 - $7.75 | $7.12 |
| Upside | -27.0% - -13.1% | -20.0% |
| Benchmarks | Ticker | Full Ticker |
| Alphatec Holdings, Inc. | ATEC | NasdaqGS:ATEC |
| Integra LifeSciences Holdings Corporation | IART | NasdaqGS:IART |
| Bioventus Inc. | BVS | NasdaqGS:BVS |
| SI-BONE, Inc. | SIBN | NasdaqGM:SIBN |
| Globus Medical, Inc. | GMED | NYSE:GMED |
| ZimVie Inc. | ZIMV | NasdaqGS:ZIMV |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| ATEC | IART | BVS | SIBN | GMED | ZIMV | ||
| NasdaqGS:ATEC | NasdaqGS:IART | NasdaqGS:BVS | NasdaqGM:SIBN | NYSE:GMED | NasdaqGS:ZIMV | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | 2.0% | 4.6% | NM- | 20.1% | NM- | |
| 3Y CAGR | NM- | -3.1% | 23.7% | NM- | 31.3% | NM- | |
| Latest Twelve Months | 22.0% | -27.8% | 97.1% | 35.6% | 52.5% | 110.1% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -33.1% | 15.4% | 2.7% | -44.9% | 18.9% | -1.7% | |
| Prior Fiscal Year | -30.7% | 16.9% | 0.4% | -33.8% | 17.4% | -2.5% | |
| Latest Fiscal Year | -20.1% | 11.3% | 7.0% | -21.1% | 17.5% | -0.5% | |
| Latest Twelve Months | -18.1% | 10.6% | 7.0% | -17.4% | 18.2% | 0.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 3.59x | 1.73x | 1.46x | 3.92x | 3.03x | 0.94x | |
| EV / LTM EBITDA | -63.9x | 8.8x | 14.1x | -26.5x | 10.6x | 11.8x | |
| EV / LTM EBIT | -19.8x | 16.2x | 20.9x | -22.6x | 16.7x | 613.5x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -22.6x | 16.2x | 20.9x | ||||
| Historical EV / LTM EBIT | -60.8x | -7.8x | 60.0x | ||||
| Selected EV / LTM EBIT | 503.0x | 529.5x | 556.0x | ||||
| (x) LTM EBIT | 1 | 1 | 1 | ||||
| (=) Implied Enterprise Value | 340 | 358 | 376 | ||||
| (-) Non-shareholder Claims * | (148) | (148) | (148) | ||||
| (=) Equity Value | 192 | 210 | 228 | ||||
| (/) Shares Outstanding | 27.9 | 27.9 | 27.9 | ||||
| Implied Value Range | 6.88 | 7.52 | 8.16 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 6.88 | 7.52 | 8.16 | 8.91 | |||
| Upside / (Downside) | -22.8% | -15.6% | -8.4% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | ATEC | IART | BVS | SIBN | GMED | ZIMV | |
| Enterprise Value | 2,304 | 2,783 | 826 | 693 | 7,620 | 397 | |
| (+) Cash & Short Term Investments | 153 | 273 | 23 | 144 | 461 | 67 | |
| (+) Investments & Other | 0 | 27 | 2 | 0 | 0 | 18 | |
| (-) Debt | (581) | (2,021) | (366) | (37) | (93) | (233) | |
| (-) Other Liabilities | 0 | 0 | (37) | 0 | 0 | 0 | |
| (-) Preferred Stock | (24) | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 1,852 | 1,062 | 447 | 800 | 7,989 | 249 | |
| (/) Shares Outstanding | 146.2 | 77.7 | 66.4 | 42.6 | 135.4 | 27.9 | |
| Implied Stock Price | 12.67 | 13.67 | 6.74 | 18.78 | 59.01 | 8.91 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 12.67 | 13.67 | 6.74 | 18.78 | 59.01 | 8.91 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |